Market Overview:
The global amenorrhea treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of amenorrhea, rising awareness about available treatments, and technological advancements in the field of amenorrhea treatment. The hormone treatment segment is expected to dominate the global amenorrhea treatment market during the forecast period. This can be attributed to factors such as rising prevalence of hormonal imbalance and growing awareness about benefits offered by hormone therapy for treating amenorrhea. In terms of application, hospitals are expected to account for a major share of the global Amenorrhea Treatment Market during the forecast period.
Product Definition:
The definition of amenorrhea is the absence of menstruation. Treatment for amenorrhea usually includes hormone therapy to stimulate periods. Amenorrhea can be caused by a variety of factors, including hormonal imbalance, stress, and weight loss. Treatment is important because without it, women can develop health problems such as osteoporosis.
Hormone Treatment:
Hormone treatment is used for the replacement of hormones in the body which are responsible for regulating menstrual cycle and ovulation. Hormone deficiency leads to various associated conditions such as menopausal symptoms, infertility, etc. The major symptom of hormonal imbalance is amenorrhea which means absence of menstrual cycle.
According to studies conducted by American Academy of Family Physicians (2016), approximately 20% women between 40-60 years have some degree of hypogonadism i.
Oral Birth Control Pills:
Oral birth control pills are a new type of contraceptive that works by preventing implantation within the uterus. They do not protect against STDs, pregnancy, or HIV infection. The drug is currently approved for use in women who have had one child and are at risk of getting pregnant.
Application Insights:
The others application segment held the largest share of more than 50.0% in 2017. The other applications include surgical menopause, endometrial ablation and ovarian drilling. Surgical menopause is expected to be the fastest-growing segment owing to increasing awareness about this treatment option among women above 40 years of age who have had a hysterectomy procedure for various reasons such as cancer or because they are postmenopausal. Endometrial ablation is also expected to witness significant growth over the forecast period due to its high success rate and low risk compared with other options such as hormone therapy or ovary drilling surgery for amenorrhea treatment available in hospitals only thus limiting its availability in outpatient clinics and hospitals which may result into higher demand for oral birth control pills among women seeking treatments worldwide during 2018-2030 period.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of Amenorrhea clinics and high healthcare expenditure are some factors contributing to its largest share. In addition, increasing awareness about amenorrhea treatment options is also one of the major reasons responsible for its large share. According to a study published in Obstetrics & Gynecology by CDC, approximately 15% - 20% females between 15 and 19 years have oligomenorrhea or amenorrhea ( irregular menstrual cycles).
Asia Pacific is expected to be the fastest-growing region over the forecast period due to rising healthcare expenditure in this region as well as growing population with menstrual cycle irregularities. Moreover, increasing awareness about various available treatments for menorrhagia will drive this regional market further. For instance, according to WebMD LLC.
Growth Factors:
- Increasing incidence of amenorrhea
- Growing awareness about the available treatments for amenorrhea
- Rising demand for effective and safe treatments for amenorrhea
- Technological advancements in the field of amenorrhea treatment
- Availability of affordable and accessible treatment options
Scope Of The Report
Report Attributes
Report Details
Report Title
Amenorrhea Treatment Market Research Report
By Type
Hormone Treatment, Oral Birth Control Pills, Others
By Application
Hospital, Clinics
By Companies
Teva Pharmaceuticals USA, Inc., Pfizer Inc., Dr. Reddy’s Laboratories, Inc., Akorn, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
182
Number of Tables & Figures
128
Customization Available
Yes, the report can be customized as per your need.
Global Amenorrhea Treatment Market Report Segments:
The global Amenorrhea Treatment market is segmented on the basis of:
Types
Hormone Treatment, Oral Birth Control Pills, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Teva Pharmaceuticals USA, Inc.
- Pfizer Inc.
- Dr. Reddy’s Laboratories, Inc.
- Akorn, Inc.
Highlights of The Amenorrhea Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hormone Treatment
- Oral Birth Control Pills
- Others
- By Application:
- Hospital
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Amenorrhea Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Amenorrhea treatment is a medical procedure that restores menstrual cycles in women who have difficulty getting pregnant or who have stopped having periods. Amenorrhea treatment may involve medications, surgery, or both.
Some of the major players in the amenorrhea treatment market are Teva Pharmaceuticals USA, Inc., Pfizer Inc., Dr. Reddy’s Laboratories, Inc., Akorn, Inc..
The amenorrhea treatment market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Amenorrhea Treatment Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Amenorrhea Treatment Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Amenorrhea Treatment Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Amenorrhea Treatment Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Amenorrhea Treatment Market Size & Forecast, 2018-2028 4.5.1 Amenorrhea Treatment Market Size and Y-o-Y Growth 4.5.2 Amenorrhea Treatment Market Absolute $ Opportunity
Chapter 5 Global Amenorrhea Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Amenorrhea Treatment Market Size Forecast by Type
5.2.1 Hormone Treatment
5.2.2 Oral Birth Control Pills
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Amenorrhea Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Amenorrhea Treatment Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Amenorrhea Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Amenorrhea Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Amenorrhea Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Amenorrhea Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Amenorrhea Treatment Market Size Forecast by Type
9.6.1 Hormone Treatment
9.6.2 Oral Birth Control Pills
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Amenorrhea Treatment Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Amenorrhea Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Amenorrhea Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Amenorrhea Treatment Market Size Forecast by Type
10.6.1 Hormone Treatment
10.6.2 Oral Birth Control Pills
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Amenorrhea Treatment Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Amenorrhea Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Amenorrhea Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Amenorrhea Treatment Market Size Forecast by Type
11.6.1 Hormone Treatment
11.6.2 Oral Birth Control Pills
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Amenorrhea Treatment Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Amenorrhea Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Amenorrhea Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Amenorrhea Treatment Market Size Forecast by Type
12.6.1 Hormone Treatment
12.6.2 Oral Birth Control Pills
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Amenorrhea Treatment Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Amenorrhea Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Amenorrhea Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Amenorrhea Treatment Market Size Forecast by Type
13.6.1 Hormone Treatment
13.6.2 Oral Birth Control Pills
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Amenorrhea Treatment Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Amenorrhea Treatment Market: Competitive Dashboard
14.2 Global Amenorrhea Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Teva Pharmaceuticals USA, Inc.
14.3.2 Pfizer Inc.
14.3.3 Dr. Reddy’s Laboratories, Inc.
14.3.4 Akorn, Inc.